pimavanserin 34 MG Oral Capsule [Nuplazid]
RxNorm concept 2049278, branded drug (sbd). Prescribable name: NUPLAZID 34 MG Oral Capsule.
- RxCUI
- 2049278
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2049278 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Nuplazid 34 MG Oral Capsule; pimavanserin 34 mg (as pimavanserin tartrate 40 MG) Oral Capsule [Nuplazid]
Related concepts
- pimavanserin 34 MG (SCDC, consists of)
- pimavanserin 34 MG [Nuplazid] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- Nuplazid (BN, has ingredient)
- pimavanserin 34 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2049278 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2049278 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2049278. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.